Medicine Description rivaxel 1.5mg
Rivaxel 1.5 mg 28 capsules is a medication that combines two active ingredients, memantine and rivastigmine, which target different aspects of Alzheimer's disease pathology. Memantine operates as an N-methyl-D-aspartate (NMDA) receptor antagonist, modulating glutamate activity, which is crucial for synaptic plasticity and memory function. By preventing excessive glutamate signaling, memantine helps reduce neuronal excitotoxicity, thereby protecting brain cells from degeneration. On the other hand, rivastigmine is a reversible inhibitor of acetylcholinesterase, which leads to increased levels of acetylcholine, a neurotransmitter essential for cognitive processes. This dual-action approach not only helps in enhancing cognitive function but also supports the overall management of symptoms associated with Alzheimer's disease.
Indications and Uses of Rivaxel 1.5 mg 28 capsules
- Treatment of mild to moderate Alzheimer’s disease
- Management of symptoms of dementia associated with Alzheimer's disease
Side Effects of Rivaxel 1.5 mg 28 capsules
- Nausea
- Vomiting
- Diarrhea
- Dizziness
- Fatigue
- Loss of appetite
- Insomnia
- Headache
Storage and Handling
Store Rivaxel capsules at room temperature, away from moisture and heat. Keep the medication out of reach of children and do not use it after the expiration date printed on the package.
Patient Advice and Precautions
Patients should take Rivaxel exactly as prescribed by a healthcare provider. Regular follow-up appointments are essential to assess effectiveness and monitor for potential side effects. Patients and caregivers should be aware of the importance of adherence to the treatment regimen and report any new or worsening symptoms to their healthcare professional.